---
figid: PMC5822899__IJE2018-2637418.002
figlink: /pmc/articles/PMC5822899/figure/fig2/
number: Figure 2
caption: 'Schematic illustration of the main intracellular pathways underlying WAT
  metabolic functions and the effects of drugs used in dyslipidemia and obesity on
  these pathways: B-oxidation (∗through upregulation of ACS, CD36, MCD, and CPT1 genes
  and after stimulus as PPARα agonist or adrenergic agonists, through upregulation
  of the AMPK pathway); lipolysis (sequentially by ATGL, HSL, and MGL actions); lipogenesis
  (∗through upregulation of GLUT4; ACC genes). Statins induce adipocyte FA uptake,
  increasing LPL expression, while decreasing cholesterol release. ∗Only in obese
  models, statins stimulate lipogenesis de novo; globally, fibrates inhibit lipogenesis
  and stimulate FA oxidation and thermogenesis (∗through upregulation of PRDM16, PPAR-γ,
  and UCP-1 gene expression); niacin inhibits lipolysis and increases lipogenesis
  gene expression; orlistat enhances TG degradation. See text for more details. →:
  stimulates; ⊣: inhibits; TG: triglycerides; FA: fatty acid; Ch: cholesterol; LPL:
  lipoprotein lipase; VLDL: very low-density lipoproteins; DGAT: diacylglycerol acyltransferase;
  ACC: enzyme acetyl-coenzyme A carboxylase; SREBP1: sterol regulatory element-binding
  protein 1; ChREBP: carbohydrate response element-binding protein; GLUT4: glucose
  transporter type 4; PI3-K: phosphoinositide 3-kinase dependent; PDE3B: phosphodiesterase
  3B; AC: adenylyl cyclase; cAMP: cyclic adenosine monophosphate; PKA: cAMP-dependent
  protein kinase A; PKB/Akt: protein kinase B; GC activity: guanylyl cyclase activity;
  cGMP: cyclic guanosine monophosphate; PKG: cGMP-dependent protein kinase; ATGL:
  adipocyte triglyceride lipase; HSL: hormone-sensitive lipase; MGL: monoacylglycerol
  lipase; PPARs: peroxisome proliferator-activated receptors; PGC-1a: peroxisome proliferator-activated
  receptor G coactivator 1; ACS: acyl-CoA synthetase; CD36/FAT: fatty acid translocase;
  CPT1: carnitine palmitoyl transferase 1; AR: adrenoceptors; ANP/BNP: atrial or brain
  natriuretic peptide; NPR-A: natriuretic receptor A; IR: insulin receptor; IRS: insulin
  receptor substrate; AMPK: adenosine monophosphate-activated protein kinase; SIRT1:
  sirtuin 1; BAT: brown adipose tissue; HDLs: high-density lipoproteins; LXRα: liver
  X receptor alpha; ABCA1 transporter: ATP-binding cassette A1 transporter; SRB1:
  scavenger-receptor 1.'
pmcid: PMC5822899
papertitle: 'Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose
  Tissue.'
reftext: Sofia Dias, et al. Int J Endocrinol. 2018;2018:2637418.
pmc_ranked_result_index: '168040'
pathway_score: 0.5790193
filename: IJE2018-2637418.002.jpg
figtitle: 'Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose
  Tissue.'
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5822899__IJE2018-2637418.002.html
  '@type': Dataset
  description: 'Schematic illustration of the main intracellular pathways underlying
    WAT metabolic functions and the effects of drugs used in dyslipidemia and obesity
    on these pathways: B-oxidation (∗through upregulation of ACS, CD36, MCD, and CPT1
    genes and after stimulus as PPARα agonist or adrenergic agonists, through upregulation
    of the AMPK pathway); lipolysis (sequentially by ATGL, HSL, and MGL actions);
    lipogenesis (∗through upregulation of GLUT4; ACC genes). Statins induce adipocyte
    FA uptake, increasing LPL expression, while decreasing cholesterol release. ∗Only
    in obese models, statins stimulate lipogenesis de novo; globally, fibrates inhibit
    lipogenesis and stimulate FA oxidation and thermogenesis (∗through upregulation
    of PRDM16, PPAR-γ, and UCP-1 gene expression); niacin inhibits lipolysis and increases
    lipogenesis gene expression; orlistat enhances TG degradation. See text for more
    details. →: stimulates; ⊣: inhibits; TG: triglycerides; FA: fatty acid; Ch: cholesterol;
    LPL: lipoprotein lipase; VLDL: very low-density lipoproteins; DGAT: diacylglycerol
    acyltransferase; ACC: enzyme acetyl-coenzyme A carboxylase; SREBP1: sterol regulatory
    element-binding protein 1; ChREBP: carbohydrate response element-binding protein;
    GLUT4: glucose transporter type 4; PI3-K: phosphoinositide 3-kinase dependent;
    PDE3B: phosphodiesterase 3B; AC: adenylyl cyclase; cAMP: cyclic adenosine monophosphate;
    PKA: cAMP-dependent protein kinase A; PKB/Akt: protein kinase B; GC activity:
    guanylyl cyclase activity; cGMP: cyclic guanosine monophosphate; PKG: cGMP-dependent
    protein kinase; ATGL: adipocyte triglyceride lipase; HSL: hormone-sensitive lipase;
    MGL: monoacylglycerol lipase; PPARs: peroxisome proliferator-activated receptors;
    PGC-1a: peroxisome proliferator-activated receptor G coactivator 1; ACS: acyl-CoA
    synthetase; CD36/FAT: fatty acid translocase; CPT1: carnitine palmitoyl transferase
    1; AR: adrenoceptors; ANP/BNP: atrial or brain natriuretic peptide; NPR-A: natriuretic
    receptor A; IR: insulin receptor; IRS: insulin receptor substrate; AMPK: adenosine
    monophosphate-activated protein kinase; SIRT1: sirtuin 1; BAT: brown adipose tissue;
    HDLs: high-density lipoproteins; LXRα: liver X receptor alpha; ABCA1 transporter:
    ATP-binding cassette A1 transporter; SRB1: scavenger-receptor 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - TLR5
  - CEBPG
  - TLR4
  - CEBPD
  - CEBPE
  - CD40LG
  - MAPK1
  - PRKACG
  - CCL2
  - JTB
  - CEBPA
  - CEBPB
  - TNF
  - PRKACA
  - PRKACB
  - EDN1
  - TLR8
  - TLR9
  - TLR1
  - TLR2
  - TLR3
  - ADCY1
  - ADCY2
  - TLR10
  - ADCY3
  - ADCY5
  - PRKAR1A
  - PRKAR1B
  - TLR7
  - ADCY4
  - ADCY10
  - CALM1
  - CD40
  - IL12B
  - IL6
  - ADCY6
  - VCAM1
  - PRKAR2A
  - PRKAR2B
  - EMD
  - CX3CL1
  - IL12A
  - ADCY8
  - ADCY9
  - TLR6
  - ADCY7
  - Statins
  - Cortisol
  - Niacin
  - Sbutramine
  - Ssibutamine
  - 'N'
  - Sibutramine
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: CEBP
  symbol: CEBP
  source: bioentities_symbol
  hgnc_symbol: CEBPG
  entrez: '1054'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: CEBP
  symbol: CEBP
  source: bioentities_symbol
  hgnc_symbol: CEBPD
  entrez: '1052'
- word: CEBP
  symbol: CEBP
  source: bioentities_symbol
  hgnc_symbol: CEBPE
  entrez: '1053'
- word: CD40L
  symbol: CD40L
  source: hgnc_alias_symbol
  hgnc_symbol: CD40LG
  entrez: '959'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: MCP-1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: PAR
  symbol: PAR
  source: hgnc_alias_symbol
  hgnc_symbol: JTB
  entrez: '10899'
- word: CEBP
  symbol: CEBP
  source: bioentities_symbol
  hgnc_symbol: CEBPA
  entrez: '1050'
- word: CEBP
  symbol: CEBP
  source: bioentities_symbol
  hgnc_symbol: CEBPB
  entrez: '1051'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNFA
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: ET-1
  symbol: ET1
  source: hgnc_alias_symbol
  hgnc_symbol: EDN1
  entrez: '1906'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: CAM-I
  symbol: CAMI
  source: hgnc_alias_symbol
  hgnc_symbol: CALM1
  entrez: '801'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: IL12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12B
  entrez: '3593'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: VCAM-1
  symbol: VCAM1
  source: hgnc_symbol
  hgnc_symbol: VCAM1
  entrez: '7412'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: -STA
  symbol: STA
  source: hgnc_alias_symbol
  hgnc_symbol: EMD
  entrez: '2010'
- word: Fractalkine
  symbol: fractalkine
  source: hgnc_alias_symbol
  hgnc_symbol: CX3CL1
  entrez: '6376'
- word: IL12
  symbol: IL12
  source: bioentities_symbol
  hgnc_symbol: IL12A
  entrez: '3592'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
chemicals:
- word: Statins
  source: MESH
  identifier: D019821
- word: Cortisol
  source: MESH
  identifier: D006854
- word: Niacin
  source: MESH
  identifier: D009525
- word: Sbutramine
  source: ''
  identifier: ''
- word: Ssibutamine
  source: ''
  identifier: ''
- word: 'N'
  source: MESH
  identifier: D009584
- word: Sibutramine
  source: MESH
  identifier: C058254
diseases: []
---
